Their reply is vague. No measures have been undertaken yet. But they are running out of time. 400k won't bring them through the March-quarter. So no good Partner for CM8
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025